Taho Pharma Submits NDA For TAH3311 Oral Dissolving Film To FDA
01 Oct 2025 //
PR NEWSWIRE
TAHO Reports Positive Pivotal Study For Oral Anticoagulant
17 Feb 2025 //
PR NEWSWIRE
Taho Completes Pivotal Trial Of Oral Dissolving Anticoagulant
21 Jan 2025 //
PR NEWSWIRE